SYNIMMUNE Competitors and Similar CompaniesClear all
SYNIMMUNE's competitors and similar companies include AnaptysBio and Allogene Therapeutics.
 SYNIMMUNE SYNIMMUNE is a biotechnology company dedicated to the development of mono- and bispecific anti-tumor antibodies. |  AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | |
Founding Date | Founding Date 2010 | Founding Date 2005 | Founding Date 2018 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Tübingen, DE HQ | Locations San Diego, US HQ San Diego, US | Locations South San Francisco, US HQ |
Employees | Employees 5 | Employees 898% decrease | Employees 2263% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 930.2 m | Valuation ($) 585.5 m |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 83.9m | Total funding raised $ 532m |
For sources of this data, please see the company profile
View Company Profiles
AnaptysBio
HQ
San Diego, US
Employees
89↓ 8% decrease
AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company